Oneness Biotech Co., Ltd. (LUX:ONEA)

Oneness Biotech Statistics

Total Valuation

Oneness Biotech has a market cap or net worth of EUR 843.02 million. The enterprise value is 705.21 million.

Market Cap	843.02M
Enterprise Value	705.21M

Important Dates

The next estimated earnings date is Tuesday, November 11, 2025.

Earnings Date	Nov 11, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.36%
Shares Change (QoQ)	+0.02%
Owned by Insiders (%)	8.60%
Owned by Institutions (%)	6.45%
Float	302.68M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	257.20
PB Ratio	2.65
P/TBV Ratio	3.09
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-12.71
EV / Sales	223.90
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-38.04

Financial Position

The company has a current ratio of 36.62, with a Debt / Equity ratio of 0.04.

Current Ratio	36.62
Quick Ratio	35.57
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	-0.63
Interest Coverage	-103.54

Financial Efficiency

Return on equity (ROE) is -15.48% and return on invested capital (ROIC) is -4.66%.

Return on Equity (ROE)	-15.48%
Return on Assets (ROA)	-4.51%
Return on Invested Capital (ROIC)	-4.66%
Return on Capital Employed (ROCE)	-8.24%
Revenue Per Employee	76,226
Profits Per Employee	-1.29M
Employee Count	43
Asset Turnover	0.01
Inventory Turnover	0.63

Taxes

In the past 12 months, Oneness Biotech has paid 68,833 in taxes.

Income Tax	68,833
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -51.85% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-51.85%
50-Day Moving Average	11.37
200-Day Moving Average	11.15
Relative Strength Index (RSI)	38.26
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Oneness Biotech had revenue of EUR 3.28 million and -55.49 million in losses. Loss per share was -0.12.

Revenue	3.28M
Gross Profit	1.17M
Operating Income	-27.87M
Pretax Income	-55.98M
Net Income	-55.49M
EBITDA	-18.06M
EBIT	-27.87M
Loss Per Share	-0.12

Balance Sheet

The company has 168.70 million in cash and 11.76 million in debt, giving a net cash position of 156.94 million.

Cash & Cash Equivalents	168.70M
Total Debt	11.76M
Net Cash	156.94M
Net Cash Per Share	n/a
Equity (Book Value)	318.12M
Book Value Per Share	0.64
Working Capital	172.13M

Cash Flow

In the last 12 months, operating cash flow was -17.39 million and capital expenditures -1.15 million, giving a free cash flow of -18.54 million.

Operating Cash Flow	-17.39M
Capital Expenditures	-1.15M
Free Cash Flow	-18.54M
FCF Per Share	n/a

Margins

Gross Margin	35.67%
Operating Margin	-850.37%
Pretax Margin	-1,707.89%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Oneness Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.36%
Shareholder Yield	-0.36%
Earnings Yield	-6.58%
FCF Yield	-2.20%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Oneness Biotech has an Altman Z-Score of 34.44 and a Piotroski F-Score of 2.

Altman Z-Score	34.44
Piotroski F-Score	2